Evidence map›Paper›PMID 33357233›Full record

ArticleGenome biology2020

Potentially adaptive SARS-CoV-2 mutations discovered with novel spatiotemporal and explainable AI models.

Michael R Garvin, Erica T Prates, Mirko Pavicic, Piet Jones, B Kirtley Amos, Armin Geiger, Manesh B Shah, Jared Streich, Joao Gabriel Felipe Machado Gazolla, David Kainer and 5 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Antiviral Strategies Against SARS-CoV-2: A Systems Biology Approach.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Michael R GarvinOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
Erica T PratesOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
Mirko PavicicOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
Piet JonesOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
B Kirtley AmosOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
Armin GeigerOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
Manesh B ShahOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
Jared StreichOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
Joao Gabriel Felipe Machado GazollaOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
David KainerOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
Ashley CliffOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
Jonathon RomeroOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA.
Nathan KeithLawrence Berkeley National Laboratory, Environmental Genomics & Systems Biology, Berkeley, CA, USA.
James B BrownLawrence Berkeley National Laboratory, Environmental Genomics & Systems Biology, Berkeley, CA, USA.
Daniel JacobsonOak Ridge National Laboratory, Biosciences Division, Oak Ridge, TN, USA. jacobsonda@ornl.gov.ORCID 0000-0002-9822-8251
Oak Ridge National Laboratory · USLawrence Berkeley National Laboratory · US

Funding

U.S. Department of Energy LOIS:10074U.S. Department of Energy Office of Science through the National Virtual Biotechnology Laboratory
6 · The paper itself

Abstract

backgroundA mechanistic understanding of the spread of SARS-CoV-2 and diligent tracking of ongoing mutagenesis are of key importance to plan robust strategies for confining its transmission. Large numbers of available sequences and their dates of transmission provide an unprecedented opportunity to analyze evolutionary adaptation in novel ways. Addition of high-resolution structural information can reveal the functional basis of these processes at the molecular level. Integrated systems biology-directed analyses of these data layers afford valuable insights to build a global understanding of the COVID-19 pandemic.

resultsHere we identify globally distributed haplotypes from 15,789 SARS-CoV-2 genomes and model their success based on their duration, dispersal, and frequency in the host population. Our models identify mutations that are likely compensatory adaptive changes that allowed for rapid expansion of the virus. Functional predictions from structural analyses indicate that, contrary to previous reports, the Asp

conclusionsThese results provide valuable insights for the development of drugs and surveillance strategies to combat the current and future pandemics.

Indexed as

Adaptation, BiologicalEvolution, MolecularModels, GeneticArtificial IntelligenceGenome, ViralHaplotypesMutationSARS-CoV-2Selection, GeneticViral ProteinsViral ProteinsAdaptive mutationCoronavirusCOVID-19Local adaptationMolecular evolutionSARS-CoV-2

Identifiers

PMID33357233
PMCPMC7756312
OpenAlexW3116123883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.